drug
influenza vaccine
updated 5mo agoby Curtin University
community read0 votes
🐶 often sniffed alongside
top 4all catalysts(1)
Trials studying influenza vaccine
- phase3A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
- phase2A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
- phase2A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above
- phase1Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)
- phase3A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
- phase2A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older
- phase2Clinical Trials of Quadrivalent Influenza Vaccine
- N/AStructured Review: To Optimise Management and Prevent Harm in COPD
News(10)
- CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potentialCSL will co-develop and co-promote Alentis Therapeutics' anti-claudin-1 therapy lixudebart for kidney and liver conditions, including primary sclerosing cholangitis and a systemic autoimmune diseas…biospace · 4d ago
- STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and moreVaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition with Pfizer and Merckstat · 4d ago
- GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modalityGSK’s vaccine—which targets two primary flu antigens—elicited higher immune responses in both younger and older adults in a mid-stage study. The Phase 3 launch, planned for September, follows the F…biospace · 1mo ago
- GSK catches phase 3 fever after mRNA flu vaccine beats standard shotsGSK has linked its mRNA seasonal flu vaccine candidate to higher immune responses than conventional jabs in a phase 2 trial, emboldening the company to start a pivotal study this month.fiercebiotech · 1mo ago
- Osivax bags flu vaccine rights to pursue combination shot visionOsivax has licensed an influenza vaccine from GC Biopharma, positioning the biotech to build on early evidence that its midphase candidate complements traditional flu shots.fiercebiotech · 1mo ago
- STAT+: Two FDA approvals — a new drug and a new vaccineTakeda's narcolepsy drug approved, the first mRNA flu shot approved, and more biotech updates from The Readoutstat · 2mo ago
- STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and moreIn today's Pharmalittle newsletter: Moderna's mRNA flu shot approved, a death reported in a gene-editing trial in China, and more.stat · 2mo ago
- Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was“The United States invented this platform and is the only country walking away from it,” Jeff Coller writes of mRNA vaccines.stat · 2mo ago
- Covid can reactivate dormant viruses, according to studyA CDC director officially confirmed, Moderna's mRNA flu shot approved, and other health news from Morning Roundsstat · 2mo ago
- FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.stat · 2mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that